Literature DB >> 7525969

Human immunodeficiency virus type 1 tat directs transcription through attenuation sites within the mouse c-myc gene.

S Wright1, X Lu, B M Peterlin.   

Abstract

The regulation of transcriptional elongation plays a central role in the expression of a number of cellular and viral genes. For example, levels of c-myc RNA change during cellular proliferation and differentiation via alterations in transcriptional attenuation near the 5' end of the c-myc gene. The protein that regulates transcription through attenuation sites in c-myc has not been identified. However, a candidate protein of equivalent function exists in the human immunodeficiency virus (HIV) genome, where the transactivator Tat increases transcriptional elongation through the HIV LTR and coding sequences by interacting with the trans-acting-response (TAR) RNA stem-loop that is found at the 5' end of all viral transcripts. By placing TAR 3' to the P2 promoter of the mouse c-myc gene, we demonstrate that Tat can also direct read-through transcription in mouse c-myc in transfected HeLa cells. Thus we identified a viral transactivator whose cellular counterpart regulates transcriptional attenuation within c-myc and other proto-oncogenes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525969     DOI: 10.1016/0022-2836(94)90031-0

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

Review 1.  The rising challenge of non-AIDS-defining cancers in HIV-infected patients.

Authors:  John F Deeken; Angelique Tjen-A-Looi; Michelle A Rudek; Catherine Okuliar; Mary Young; Richard F Little; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2012-07-09       Impact factor: 9.079

Review 2.  Lung cancer in HIV-infected patients in the combination antiretroviral treatment era.

Authors:  José Moltó; Teresa Moran; Guillem Sirera; Bonaventura Clotet
Journal:  Transl Lung Cancer Res       Date:  2015-12

3.  Effects of heterologous downstream sequences on the activity of the HIV-1 promoter and its response to Tat.

Authors:  M E Greenberg; M B Mathews
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

4.  The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.

Authors:  T P Cujec; H Okamoto; K Fujinaga; J Meyer; H Chamberlin; D O Morgan; B M Peterlin
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

Review 5.  Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.

Authors:  Paul G Rubinstein; David M Aboulafia; Andrew Zloza
Journal:  AIDS       Date:  2014-02-20       Impact factor: 4.177

6.  Cell cycle regulation of RNA polymerase III transcription.

Authors:  R J White; T M Gottlieb; C S Downes; S P Jackson
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

Review 7.  Non-AIDS-defining cancers among HIV-infected patients.

Authors:  James Cutrell; Roger Bedimo
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

8.  Serious Non-AIDS events: Immunopathogenesis and interventional strategies.

Authors:  Denise C Hsu; Irini Sereti; Jintanat Ananworanich
Journal:  AIDS Res Ther       Date:  2013-12-13       Impact factor: 2.250

9.  Prevalence of HPV-DNA and E6 mRNA in lung cancer of HIV-infected patients.

Authors:  Guillem Sirera; Sebastián Videla; Verónica Saludes; Eva Castellà; Carolina Sanz; Aurelio Ariza; Bonaventura Clotet; Elisa Martró
Journal:  Sci Rep       Date:  2022-08-01       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.